Transient hyperthyroidism after surgery for secondary hyperparathyroidism: a common problem

European Journal of Medical Research

B Isermann³  PP Nawroth³  IA Grafe³  S Kopf³  C Leowardi¹  P Reismann²  M Tsioga³  G Rudofsky³ 

[1] Department of General Surgery, University of Heidelberg, Heidelberg, Germany;Second Department of Medicine, Semmelweis University, Budapest, Hungary;Department of Endocrinology and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany

关键词: thyroglobulin;    parathyroidectomy;    palpation thyroiditis;    secondary hyperparathyroidism;    hyperthyroidism;   

Others  :  824904
DOI  :  10.1186/2047-783X-16-8-375

 received in 2011-03-29, accepted in 2011-04-11,  发布年份 2011

【 摘 要 】

Background

Postoperative hyperthyroidism occurs in approximately one third of patients following parathyroidectomy due to primary hyperparathyroidism (PHP), but has only rarely been described in secondary hyperparathyroidism (SHP). The frequency, course, and laboratory markers of postoperative hyperthyroidism in SHP remain unknown. Our purpose was to evaluate the frequency and the clinical course of postoperative hypcrthyroidism following surgery of SHP and to determine the diagnostic value of thyroglobulin in this setting.

Material and Methods

A total of 40 patients undergoing parathyroidectomy because of SHP were included in this study. Thyroid stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fl4), and thyroglobulin (Tg) were determined one day before and on day 1, 3, 5, 10, and 40 after surgery. At each of these visits patients were clinically evaluated for signs or symptoms of hyperthyroidism.

Results

Biochemical evidence of hyperthyroidism was evident in 77% of patients postoperatively despite of preoperatively normal serum levels. TSH dropped from 1.18 ± 0.06mU/L to 0.15 ± 0.07mU/L (p = 0.0015). Free triiodothyronine (fT3) and fT4 levels increased from 2.86 ± 0.02ng/L and 10.32 ± 0.13ng/L, respectively, to their maximum of 4.83 ± 0.17ng/L and 19.35 ± 0.58ng/L, respectively. Thyroglobulin levels rose from 3.8 ± 0.8ng/mL to 111.8 ± 45.3ng/mL (p < 0.001). At day 40 all thyroid related laboratory values were within normal range. Correlation analysis of postoperative values revealed significant correlations for lowest TSH (r = -0.32; p = 0.038), and highest fT3 (r = 0.55; p < 0.001) and fT4 levels (r = 0.67; p < 0.001) with Tg.

Conclusion

Transient hyperthyroidism is frequent after parathyroidectomy for SHP with Tg being a suitable marker. Awareness of this self-limiting disorder is important to avoid inappropriate and potentially harmful treatment.

【 授权许可】

   
2011 I Holzapfel Publishers

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Lindberg JS, Culleton B, Wong G, Borah MP, Clark RV, Shapiro WB, Roger SD, Husserl FE, Klassen PS, Guo MD, Albizem MB, Coburn JW: Cinacalcet HC1, an oral calcimimctic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomised, double-blind, multicenter study. J Am Soc Nephrol 2005, 16:800-7.
• [2]Fraser WD: Hyperparathyroidism. Lancet 2009, 374:145-158.
• [3]Kebebew E, Duh QY, Clark OH: Tertiary hyperparathyroidism: histologic patterns of disease and results of patathyrbidectomy. Arch Surg 2004, 139:974-7.
• [4]Triponez F, Kebebew E, Dosseh D, Duh QY, Hazzan M, Noel C, Chertow GM, Wambergue F, Fleury D, Lemaitre V, Proye CA, Clark OH: Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery 2006, 140:990-7.
• [5]Walfish PG, Caplan D, Rosen IB: Postparathyroidectomy transient thyrotoxicosis. J Clin Endocrinol Metab 1992, 75:224-7.
• [6]Lindblom P, Valdemarsson S, Westerdahl j, Tennvall J, Bergenfelz A: Hyperthyroidism after surgery for primary hyperparathyroidism. Langenbecks Arch Surg 1999, 384:568-75.
• [7]Musi N, Braverman LE, Norris CM Jr: Severe thyrotoxicosis after parathyroid surgery for hyperparathyroidism. Am j Med 2000, 108:519-20.
• [8]Stang MT, Yim JH, Challinor SM, Bahl S, Carty SE: Hyperthyroidism after parathyroid exploration. Surgery 2005, 138:1058-64.
• [9]Lederer SR, Schiffl H: Transient hyperthyroidism after total parathyroidectomy for tertiary hyperparathyroidism: a report of two cases. Wien Klin Wochenschr 2008, 120:432-4.
• [10]Sato H, Miyamoto Y, Inagaki M, Kanai G, Suzuki H, Tanaka R, Kakuta T, Saito A: Atrial fibrillation induced by post-paratlmoidectomy transient thyrotoxicosis. Intern Med 2008, 47:1807-11.
• [11]Rudofsky G Jr, Grafe I A, Metzner C, Leowardi C, Fohr B: Transient post-operative thyrotoxicosis after parathyroidectomy. Med Sci Monit 2009, 15:CS41-3.
• [12]Hwang TS, Park SH: Histopathologic study of the so called 'palpadon thyroiditis'. J Korean Med Sci 1988, 3:27-9.
• [13]Warner MH, Beckett GJ: Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010, 205:1-13.
• [14]Heizmann O, Viehl CT, Schmid R, Muller-Brand J, Müller B, Oertli D: Impact of concomitant thyroid pathology on preoperadve workup for primary hyperparathyroidism. European Journal of Medical Research 2009, 28:37-41.
• [15]McGowan DM, Vaswani A, Shperling I: Coexisting hyperparathyroidism with thyrotoxicosis. J Endocrinol Invest 1991, 14:305-10.
• [16]Jansson S, Lie-Karlsen K, Stenqvist O, Körner U, Lundholm K, Tisell LE: Oxygen consumpdon in patients with hyperthyroidism before and after treatment with beta-blockade versus thyrostadc treatment: a prospective randomized study. Annals of Surgery 2001, 233:60-4.
• [17]Nayak B, Burman K: Thyrotoxicosis and thyroid storm. Endocrinology and Metabolism Clinics of North America 2006, 35:663-86.
• [18]Lin JD: Thyroglobulin and human thyroid cancer (2008). Clin Chim Acta 2008, 388:15-21.
• [19]Brown RS: Autoimmune tigroid disease: unlocking a complex puzzle. Curr Opin Pediatr 2009, 21:523-8.